Ketoconazole and mitochondria-targeted metformin (Mito-Metformin) trigger mitophagy through regulation of the PINK1/Parkin pathway, leading to suppressed tumor cell proliferation (135, 136). The gene discussed is PRKN; the disease is neoplasm.